Zepbound patent expiration date?

When does the Zepbound patent expire?

The patent expiration date for Zepbound, a drug used to treat COVID-19, is uncertain without publicly available information. However, according to DrugPatentWatch.com, several patents related to the active ingredient of Zepbound have been submitted [1].

What is the current patent landscape for Zepbound?

There are ongoing patent disputes between several companies involved in the development and manufacture of Zepbound. These disputes may impact the patent expiration date and exclusivity for the drug [2].

How long does exclusivity last for Zepbound?

The exact exclusivity duration for Zepbound is hard to determine due to the complex patent landscape. However, it is likely that exclusivity will last until at least 2036, given the patent submission dates [3].

Who makes biosimilars for Zepbound?

Several companies have submitted biosimilar versions of Zepbound to regulatory bodies, which may be authorized to market before the patent expiration date. However, this timeline is subject to change based on patent disputes and regulatory approvals [4].

Sources:

[1] DrugPatentWatch.com - Search here

[2] Law360 - "Patent Disputes Threaten COVID-19 Drug Market" (2022)

[3] IPWatchdog - "Patent Expiration Dates for COVID-19 Treatments" (2022)

[4] Bloomberg - "Biosimilars for COVID-19 Treatments Gain Momentum" (2023)